Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 June 2021 | Story Xolisa Mnukwa | Photo Supplied
CUADS: Recognised for its efforts in human reconciliation within higher education spaces by creating and providing opportunities for students with disabilities to thrive academically.

In commemoration of Youth Month 2021, the South African government zooms in to uncover opportunities available to the South African youth, drawing more young people into the economy, and initiating various youth development and empowerment initiatives to support young people.

In line with this, the University of the Free State (UFS) Centre for Universal Access and Disability Support (CUADS) has established and implemented a number of technological and academic support measures to humanise the experiences of students with disabilities at the UFS, encouraging universal access and academic success for all students.  The ultimate aim is to have young people with disabilities employed in order to participate in the economy of South Africa.

CUADS continues the mission established when the department first opened: to become a higher-education institution support service recognised for its efforts in human reconciliation by creating and providing opportunities for students with disabilities to ultimately achieve academically, and to have an institutional culture of embracing and welcoming persons with disabilities on all three campuses of the UFS.

According to Martie Miranda, Assistant Director of CUADS and chair of the Higher and Further Education Disability Services Association, CUADS is monumental in its ability to accommodate the specific needs of students with sensory, physical, and learning disabilities, and has inspired other South African universities to enhance the qualities of their services by adapting their strategic visions to that of CUADS, which aims to operationalise and cater for the core needs of students through the UFS Integrated Transformation Plan (ITP), founded on the Strategic Policy Framework on Disability for the post-education and training sector. 

The UFS ITP assists in addressing physical barriers (accessibility to and within buildings, e.g., ramps, doorways, services, and information), attitudinal barriers (communication access, awareness and advocacy, integrated programmes to mix and learn between peers), and structural barriers (policies, flexible service delivery, and employment practices).

CUADS, in line with the UFS Division of Student Affairs (DSA), prioritises student success and plans to maintain continuous engagement with students (on an individual basis, but also per disability category) to continue the support needed to ensure student success.


News Archive

Carbon dioxide makes for more aromatic decaffeinated coffee
2017-10-27


 Description: Carbon dioxide makes for more aromatic decaffeinated coffee 1b Tags: Carbon dioxide makes for more aromatic decaffeinated coffee 1b 

The Inorganic Group in the Department of Chemistry
at the UFS is systematically researching the utilisation
of carbon dioxide. From the left, are, Dr Ebrahiem Botha,
Postdoctoral Fellow; Mahlomolo Khasemene, MSc student;
Prof André Roodt; Dr Marietjie Schutte-Smith, Senior Lecturer;
and Mokete Motente, MSc student.
Photo: Charl Devenish

Several industries in South Africa are currently producing hundreds of thousands of tons of carbon dioxide a year, which are released directly into the air. A typical family sedan doing around 10 000 km per year, is annually releasing more than one ton of carbon dioxide into the atmosphere.

The Inorganic Chemistry Research Group in the Department of Chemistry at the University of the Free State (UFS), in collaboration with the University of Zurich in Switzerland, has focused in recent years on using carbon dioxide – which is regarded as a harmful and global warming gas – in a meaningful way. 

According to Prof André Roodt, Head of Inorganic Chemistry at the UFS, the Department of Chemistry has for the past five decades been researching natural products that could be extracted from plants. These products are manufactured by plants through photosynthesis, in other words the utilisation of sunlight and carbon dioxide, nitrogen, and other nutrients from the soil.

Caffeine and chlorophyll 
“The Inorganic group is systematically researching the utilisation of carbon dioxide. Carbon dioxide is absorbed by plants through chlorophyll and used to make interesting and valuable compounds and sugars, which in turn could be used for the production of important new medicines,” says Prof Roodt.

Caffeine, a major energy enhancer, is also manufactured through photosynthesis in plants. It is commonly found in tea and coffee, but also (artificially added) in energy drinks. Because caffeine is a stimulant of the central nervous system and reduces fatigue and drowsiness, some people prefer decaffeinated coffee when enjoying this hot drink late at night. 

Removing caffeine from coffee could be expensive and time-consuming, but also environmentally unfriendly, because it involves the use of harmful and flammable liquids. Some of the Inorganic Group’s research focus areas include the use of carbon dioxide for the extraction of compounds, such as caffeine from plants. 

“Therefore, the research could lead to the availability of more decaffeinated coffee products. Although decaffeinated coffee is currently aromatic, we want to investigate further to ensure better quality flavours,” says Prof Roodt.

Another research aspect the team is focusing on is the use of carbon dioxide to extract chlorophyll from plants which have medicinal properties themselves. Chemical suppliers sell chlorophyll at R3 000 a gram. “In the process of investigating chlorophyll, our group discovered simpler techniques to comfortably extract larger quantities from green vegetables and other plants,” says Prof Roodt.

Medicines
In addition, the Inorganic Research Group is also looking to use carbon dioxide as a building block for more valuable compounds. Some of these compounds will be used in the Inorganic Group’s research focus on radiopharmaceutical products for the identification and possibly even the treatment of diseases such as certain cancers, tuberculosis, and malaria.

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept